ARG2 and cancer: Survival analysis demonstrated an association between the presence of ARG2-expressing stromal cells and shorter OS (P  = 0.003) and DFS (P  = 0.0006) (Figure 2), although no association was found between the presence of ARG2-expressing cancer cells and any patient survival parameter.